ACTRIMS 2023: Less frequent Ocrevus infusion not tied to gre

Greater disease activity was not evident in MS patients given a next Ocrevus infusion at times beyond the recommended every six months.

Related Keywords

San Diego , California , United States , Nicole Bou Rjeily , Abou Rjeily , Johns Hopkins , Johns Hopkins University , Genentech , Americas Committee For Treatment , Research In Multiple Sclerosis , Americas Committee , Multiple Sclerosis , Interval Dosing , Multiple Sclerosis Is Not Associated , Meaningful Differences , Disease Activity , Multiple Sclerosis News Today ,